Largest pharmaceuticals by total liabilities
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
Veradermics has the lowest figure of the 61 pharmaceuticals ranked by total liabilities, at SEK 93.2M, followed by Belite Bio (SEK 102.5M) and Oruka Therapeutics (SEK 169.9M). Figures as of 18 Nov 2026, 16:15 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- Lowest
- VeradermicsSEK 93.2M
- Median
- SEK 21.2B
- Combined market value
- SEK 51.77T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Total liabilities ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | VeradermicsMANE · Health Care | SEK 93.2M | SEK 53.3B | SEK 1,262.08 | 1.34% down | 233% up | ||
| 2 | Belite BioBLTE · Health Care | SEK 102.5M | SEK 65.8B | SEK 1,620.53 | 0.91% up | 31% up | ||
| 3 | Oruka TherapeuticsORKA · Health Care | SEK 169.9M | SEK 66.7B | SEK 983.05 | 0.24% up | 241% up | ||
| 4 | Edgewise TherapeuticsEWTX · Health Care | SEK 309M | SEK 45.6B | SEK 416.13 | 2.78% down | 88% up | ||
| 5 | Dianthus TherapeuticsDNTH · Health Care | SEK 382M | SEK 49.5B | SEK 879.50 | 0.69% down | 113% up | ||
| 6 | Protagonist TherapeuticsPTGX · Health Care | SEK 544.5M | SEK 82.8B | SEK 1,268.04 | 0.10% down | 46% up | ||
| 7 | Praxis Precision MedicinesPRAX · Health Care | SEK 608.6M | SEK 87.5B | SEK 3,130.53 | 0.79% up | 61% up | ||
| 8 | Spyre TherapeuticsSYRE · Health Care | SEK 636.8M | SEK 92.1B | SEK 969.30 | 1.48% up | 286% up | ||
| 9 | ErascaERAS · Health Care | SEK 722.7M | SEK 47.2B | SEK 134.40 | 4.97% down | 403% up | ||
| 10 | Summit TherapeuticsSMMT · Health Care | SEK 940M | SEK 87.5B | SEK 109.35 | 0.66% up | 36% down | ||
| 11 | Definium TherapeuticsDFTX · Health Care | SEK 1.1B | SEK 39.7B | SEK 289.87 | 3.10% down | 169% up | ||
| 12 | ABIVAXABVX · Health Care | SEK 1.5B | SEK 74.4B | SEK 850.18 | 1.71% up | 27% down | ||
| 13 | Corcept TherapeuticsCORT · Health Care | SEK 1.9B | SEK 75.9B | SEK 693.38 | 2.81% down | 8% down | ||
| 14 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | SEK 2B | SEK 76.9B | SEK 978.47 | 1.04% up | 126% up | ||
| 15 | Rhythm PharmaceuticalsRYTM · Health Care | SEK 2.1B | SEK 82.4B | SEK 1,188.21 | 0.08% up | 13% up | ||
| 16 | Cogent BiosciencesCOGT · Health Care | SEK 3.1B | SEK 50.3B | SEK 288.91 | 1.89% up | 20% down | ||
| 17 | TG TherapeuticsTGTX · Health Care | SEK 4.2B | SEK 99.3B | SEK 657.23 | 2.93% up | 107% up | ||
| 18 | Roivant SciencesROIV · Health Care | SEK 4.2B | SEK 286.1B | SEK 394.85 | 0.18% up | 90% up | ||
| 19 | Travere TherapeuticsTVTX · Health Care | SEK 5B | SEK 49.1B | SEK 511.58 | 1.67% down | 44% up | ||
| 20 | Mirum PharmaceuticalsMIRM · Health Care | SEK 5.4B | SEK 60.5B | SEK 927.35 | 0.95% down | 31% up | ||
| 21 | Ligand PharmaceuticalsLGND · Health Care | SEK 5.5B | SEK 61B | SEK 3,048.21 | 1.90% up | 43% up | ||
| 22 | Axsome TherapeuticsAXSM · Health Care | SEK 6.1B | SEK 71.5B | SEK 1,358.75 | 1.84% down | 7% down | ||
| 23 | Madrigal PharmaceuticalsMDGL · Health Care | SEK 6.7B | SEK 97.1B | SEK 4,179.86 | 2.72% down | 24% down | ||
| 24 | AlkermesALKS · Health Care | SEK 6.8B | SEK 79.8B | SEK 474.83 | 2.61% up | 58% up | ||
| 25 | Legend BiotechLEGN · Health Care | SEK 7.4B | SEK 32.2B | SEK 165.86 | 1.12% up | 42% down | ||
| 26 | United TherapeuticsUTHR · Health Care | SEK 8B | SEK 249.4B | SEK 5,856.34 | 1.53% down | 23% up | ||
| 27 | Arrowhead PharmaceuticalsARWR · Health Care | SEK 9B | SEK 62.3B | SEK 440.56 | 0.65% up | 10% up | ||
| 28 | BioMarin PharmaceuticalBMRN · Health Care | SEK 15.3B | SEK 118.2B | SEK 610.45 | 2.47% up | 11% up | ||
| 29 | InsmedINSM · Health Care | SEK 15.5B | SEK 268.1B | SEK 1,221.86 | 1.52% down | 40% down | ||
| 30 | Ascendis PharmaASND · Health Care | SEK 16.6B | SEK 180.2B | SEK 2,746.50 | 0.53% down | 28% up | ||
| 31 | CytokineticsCYTK · Health Care | SEK 21.2B | SEK 72.6B | SEK 521.10 | 0.91% down | 20% down | ||
| 32 | Dr. Reddy's LaboratoriesRDY · Health Care | SEK 21.5B | SEK 127.1B | SEK 152.47 | 1.25% up | 5% up | ||
| 33 | BridgeBio PharmaBBIO · Health Care | SEK 30.7B | SEK 153.9B | SEK 789.90 | 1.02% up | 17% up | ||
| 34 | Ionis PharmaceuticalsIONS · Health Care | SEK 30.9B | SEK 46.4B | SEK 278.37 | 1.41% up | 64% down | ||
| 35 | PTC TherapeuticsPTCT · Health Care | SEK 31.6B | SEK 51.3B | SEK 613.55 | 0.17% down | 20% down | ||
| 36 | Amneal PharmaceuticalsAMRX · Health Care | SEK 37.4B | SEK 76.4B | SEK 219.42 | 2.04% up | 83% up | ||
| 37 | BeOne MedicinesONC · Health Care | SEK 39B | SEK 469.6B | SEK 4,111.29 | 2.29% down | 17% up | ||
| 38 | Alnylam PharmaceuticalsALNY · Health Care | SEK 42.5B | SEK 208.3B | SEK 1,555.57 | 2.38% down | 66% down | ||
| 39 | Elanco Animal HealthELAN · Health Care | SEK 69.3B | SEK 134.1B | SEK 268.34 | 1.95% up | 20% up | ||
| 40 | Vertex PharmaceuticalsVRTX · Health Care | SEK 71B | SEK 1.38T | SEK 5,432.98 | 0.11% down | 27% up | ||
| 41 | GenmabGMAB · Health Care | SEK 71.5B | SEK 322.3B | SEK 522.73 | 1.19% down | 70% up | ||
| 42 | Jazz PharmaceuticalsJAZZ · Health Care | SEK 74.7B | SEK 159.2B | SEK 2,479.51 | 1.17% up | 37% up | ||
| 43 | Regeneron PharmaceuticalsREGN · Health Care | SEK 94.7B | SEK 1.01T | SEK 9,716.85 | 0.36% down | 36% up | ||
| 44 | Royalty PharmaRPRX · Health Care | SEK 100.9B | SEK 400.7B | SEK 696.82 | 0.35% down | 78% up | ||
| 45 | ZoetisZTS · Health Care | SEK 123.6B | SEK 346.5B | SEK 852.82 | 0.34% up | 29% down | ||
| 46 | GrifolsGRFS · Health Care | SEK 136.8B | SEK 59.1B | SEK 86.90 | 1.10% down | 1% up | ||
| 47 | ViatrisVTRS · Health Care | SEK 228.9B | SEK 241B | SEK 210.20 | 0.95% up | 96% up | ||
| 48 | Teva Pharmaceutical IndustriesTEVA · Health Care | SEK 334.3B | SEK 502.2B | SEK 430.43 | 0.81% down | 74% up | ||
| 49 | Abbott LaboratoriesABT · Health Care | SEK 345.6B | SEK 1.84T | SEK 1,061.96 | 0.39% down | 17% down | ||
| 50 | Takeda PharmaceuticalTAK · Health Care | SEK 515.3B | SEK 695.2B | SEK 217.58 | 1.25% down | 54% up | ||
| 51 | Novo NordiskNVO · Health Care | SEK 527.1B | SEK 1.78T | SEK 404.22 | 2.46% down | 17% down | ||
| 52 | GSKGSK · Health Care | SEK 610.4B | SEK 995.6B | SEK 496.67 | 0.93% down | 6% up | ||
| 53 | SanofiSNY · Health Care | SEK 622.4B | SEK 1.16T | SEK 481.85 | 0.43% down | 4% down | ||
| 54 | NovartisNVS · Health Care | SEK 655.7B | SEK 3T | SEK 1,589.93 | 1.87% down | 25% up | ||
| 55 | AstraZenecaAZN · Health Care | SEK 665.4B | SEK 2.82T | SEK 1,820.29 | 1.91% down | 2% up | ||
| 56 | Bristol-Myers SquibbBMY · Health Care | SEK 728.3B | SEK 1.25T | SEK 611.21 | 2.15% down | 34% up | ||
| 57 | Merck & CoMRK · Health Care | SEK 857.3B | SEK 3.51T | SEK 1,422.29 | 2.57% down | 51% up | ||
| 58 | Eli LillyLLY · Health Care | SEK 875B | SEK 12.6T | SEK 14,151.00 | 1.82% down | 35% up | ||
| 59 | Johnson & JohnsonJNJ · Health Care | SEK 1.2T | SEK 6.75T | SEK 2,803.24 | 1.21% down | 38% up | ||
| 60 | PfizerPFE · Health Care | SEK 1.24T | SEK 1.63T | SEK 286.72 | 1.09% down | 14% up | ||
| 61 | AbbVieABBV · Health Care | SEK 1.4T | SEK 5.19T | SEK 2,936.16 | 1.52% down | 26% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total liabilities is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Where a company reports no total-liabilities line, it is worked out as assets less equity. Sums are converted from US dollars at today's exchange rate (1 USD = 10.1817 SEK).
Questions and answers
Which pharmaceuticals have the lowest total liabilities?
Veradermics (SEK 93.2M), Belite Bio (SEK 102.5M) and Oruka Therapeutics (SEK 169.9M) have the lowest total liabilities of the 61 pharmaceuticals ranked here as of 18 Nov 2026, 16:15 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by total liabilities.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by total liabilities have a combined market value of SEK 51.77T as of 18 Nov 2026, 16:15 UTC.
What does ranking by total liabilities measure?
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceuticals by total liabilities”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=total-liabilities
Underlying data: Yahoo Finance; SEC EDGAR.